Study on Genipin: A New Alternative Natural Crosslinking Agent for Fixing Heterograft Tissue
Open Access
- 11 June 2011
- journal article
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 44 (3), 197-207
- https://doi.org/10.5090/kjtcs.2011.44.3.197
Abstract
In cardiac surgery, especially in the reconstruction of vascular structures and intracardiac defects, glutaraldehyde has usually been used as the reagent for fixing porcine or bovine pericardial tissues. But the well-known problem of calcification or cytotoxicity of glutaraldehyde motivates the search for a replacement. The aim of this study is to investigate the physical, mechanical, and biochemical characteristics of bovine pericardial tissues fixed with genipin, which is known to be a less toxic and more natural fixing reagent. Bovine pericardial tissues were fixed with different concentrations and conditions of glutaraldehyde and genipin. To determine the physical, mechanical, and biochemical differences among different concentrations and conditions, we divided the tissue into 18 groups by concentration, the addition of organic solvents, and the timing of adding the organic solvents, and compared the characteristics of each group. Tensile strength, physical activity, and thermal stability tests revealed that the tissues fixed with glutaraldehyde were better with regard to mechanical strength and biochemical durability. However, the difference was not significant statistically. Genipin can be used as an alternative crosslinking agent for pericardial tissue, considering given its physical, mechanical, biochemical characteristics and low cytotoxicity comparable to glutaraldehyde. However, further studies are needed on the immune reaction and the long term changes in genipin-fixed tissues in the human body.Keywords
This publication has 16 references indexed in Scilit:
- In vitro study in the endothelial cell compatibility and endothelialization of genipin-crosslinked biological tissues for tissue-engineered vascular scaffoldsJournal of Materials Science: Materials in Medicine, 2009
- Genipin blues: an alternative non-toxic crosslinker for heart valves?2008
- Cell-free xenogenic vascular grafts fixed with glutaraldehyde or genipin: In vitro and in vivo studiesJournal of Biotechnology, 2005
- Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potentialJournal of Biomedical Materials Research Part A, 2004
- Raman spectroscopic study of glutaraldehyde-stabilized collagen and pericardium tissueJournal of Biomaterials Science, Polymer Edition, 2003
- Reconstruction of the right ventricular outflow tract with a bovine jugular vein graft fixed with a naturally occurring crosslinking agent (genipin) in a canine modelThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Studies on the Blue Pigments Produced from Genipin and Methylamine. II. On the Formation Mechanisms of Brownish-Red Intermediates Leading to the Blue Pigment Formation.CHEMICAL & PHARMACEUTICAL BULLETIN, 1994
- Enzymic Studies on the Animal and Intestinal Bacterial Metabolism of Geniposide.Biological & Pharmaceutical Bulletin, 1994
- Inhibition of Bioprosthetic Heart Valve Calcification with Aminodiphosphonate Covalently Bound to Residual Aldehyde GroupsThe Annals of Thoracic Surgery, 1988
- Chemically modified collagen: A natural biomaterial for tissue replacementJournal of Biomedical Materials Research, 1987